Intrapulmonary delivery of tumor necrosis factor agonist peptide augments host defense in murine gram-negative bacterial pneumonia

Infection and Immunity

Volumn 66, Issue 6, 1998, Pages 2822-2826

  Laichalk, Lauri L ^a   Bucknell, Kathy A ^a   Huffnagle, Gary B ^a   Wilkowski, Jodi M ^a   Moore, Thomas A ^a   Romanelli, Robert J ^a   Standiford, Theodore J ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM IDENTIFICATION; FEMALE; GRAM NEGATIVE INFECTION; HOST RESISTANCE; IMMUNOREGULATION; INFECTION RESISTANCE; KLEBSIELLA PNEUMONIAE; LEUKOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0031839857     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.6.2822-2826.1998     Document Type: Article

References (28)

1. Bagby, G. J., K. J. Plessala, L. A. Wilson, J. J. Thompson, and S. Nelson. 1991. Divergent efficacy of antibody against tumor necrosis factor-α in intravascular and peritonitis models of sepsis. J. Infect. Dis. 163:83-88.
2. Buret, A., M. L. Dunkley, G. Pang, R. L. Clancy, and A. W. Cripps. 1994. Pulmonary immunity to Psendomonas aeruginosa in intestinally immunized rats: the role of alveolar macrophages, tumor necrosis factor, and interleukin-1. Infect. Immun. 62:5335-5343.
3. Campbell, G. D. 1994. Overview of community acquired pneumonia. Prognosis and clinical features. Med. Clin. North Am. 78:1035-1048.
4. Centers for Disease Control and Prevention. 1997. Update: Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997. Morbid. Mortal. Weekly Rep. 46:813-815.
5. Chensue, S. W., J. H. Ruth, K. Warmington, P. Lincoln, and S. L. Kunkel. 1995. In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation. J. Immunol. 155:3546-3553.
6. Davies, J. 1994. Inactivation of antibiotics and dissemination of resistance genes. Science 264:375-382.
7. Gamble, J. R., J. M. Harlan, and S. J. Klebanoff. 1985. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc. Natl. Acad. Sci. USA 82:8667-8671.
8. Goldblum, S. E., K. Wu, and M. Jay. 1985. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J. Appl. Physiol. 59:1978-1985.
9. Gosselin, D., J. DeSanctis, M. Boule, E. Skamene, C. Matouk, and D. Radzioch. 1995. Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect. Immun. 63:3272-3278.
10. Greenberger, M. J., R. M. Strieter, S. L. Kunkel, J. M. Danforth, L. L. Laichalk, D. C. McGillicuddy, and T. J. Standiford. 1996. Neutralization of MIP-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J. Infect. Dis. 173:159-165.
11. Greenberger, M. J., R. M. Strieter, S. L. Kunkel, J. M. Danforth, R. E. Goodman, and T. J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J. Immunol. 155:722-729.
12. Greenberger, M., S. L. Kunkel, R. M. Strieter, N. Lukacs, J. Bramson, J. Gauldie, F. Graham, M. Hitt, J. Danforth, and T. J. Standiford. 1996. IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J. Immunol. 157: 3006-3012.
13. Havell, E. A. 1989. Evidence that tumor necrosis factor has an important role in antibacterial resistance. J. Immunol. 143:2894-2899.
14. Jenson, W., R. Rose, A. Wasserman, T. Kalb, K. Anton, and H. Remold. 1987. In vitro activation of the antibacterial activity of human pulmonary macrophages by recombinant gamma interferon. J. Infect. Dis. 155:574-577.
15. Kolls, J. K., S. Nelson, and W. R. Summer. 1993. Recombinant cytokines and pulmonary host defense. Am. J. Med. Sci. 306:330-335.
16. Kolls, J. K., D. Lei, S. Nelson, W. R. Summer, S. Greenberg, and B. Beutler. 1995. Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endoloxic shock yet impairs pulmonary host defense. J. Infect. Dis. 171:570-575.
17. Kumaratilake, L. M., D. A. Rathjen, P. Mack, F. Widmer, V. Prasertsiriroj, and A. Ferrante. 1995. A synthetic tumor necrosis factor-α agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodinm chabaudi infection in mice. J. Clin. Invest. 95:2315-2323.
18. Laichalk, L. L., S. L. Kunkel, R. M. Strieter, J. Danforth, M. Bailie, and T. J. Standiford. 1996. Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect. Immun. 64:5211-5218.
19. Le, J., and J. Vilcek. 1987. Tumor necrosis factor and interleukin-1: cytokines with multiple overlapping biological activities. Lab. Invest. 56:234-248.
20. Maloney, S. B., and W. J. Williams. 1995. Epidemic nosocomial pneumonia in the intensive care unit. Clin. Chest. Mce. 16:209-223.
21. Moussa, K., H. J. Michie, I. A. Cree, A. C. McCafferty, J. H. Winter, D. P. Dhillion, S. Stephens, and R. A. Brown. 1994. Phagocyte function and cytokine production in community acquired pneumonia. Thorax 49:107-111.
22. Oswald, I. P., T. A. Wynn, A. Sher, and S. L. James. 1992. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor required as a costimulatory factor for interferon γ-induced activation. Immunology 89:8676-8680.
23. Rathjen, D. A., A. Ferrante, and A. Aston. 1993. Differential effects of small tumour necrosis factor-α peptides on tumour cell cytotoxicity, neutrophil activation, and endothelial cell procoagulant activity. Immunology 80:293-299.
24. Rot, A. The role of leukocyte chemotaxis in inflammation, p. 263-296. In S. Kunkel, I. Lindley, and J. Warwick (ed.), Chemotactic cytokines. Karger, Basel, Switzerland.
25. Svarva, C. W., H. Ratner, and J. A. Maeland. 1985. Emergence of β-lactam multiresistant varients of gram-negative bacilli in the presence of cefotaxime. Scand. J. Infect. Dis. 17:387-391.
26. Tan, A. M., A. Ferrante, D. H. Goh, D. M. Robertson, and A. W. Cripps. 1995. Activation of the neutrophil bactericidal activity for non typeable Haemophilus influenza by tumor necrosis factor and lymphotoxin. Ped. Res. 37:155-159.
27. Toews, G. B., G. N. Gross, and A. K. Pierce. 1980. The relationship of inoculum size to lung bacterial clearance and phagocytic cell response in mice. Am. Rev. Respir. Dis. 120:559-566.
28. Tracey, K. J., B. Beutler, S. K. Lowry, and A. Cerami. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.